Norges Bank Investment Management »

Day One Biopharmaceuticals I shares owned by Norges Bank Investment Management

Quarter-by-quarter ownership of Day One Biopharmaceuticals I (DAWN) shares owned by Norges Bank Investment Management from 13F filings

Historical chart of Norges Bank Investment Management investment in Day One Biopharmaceuticals I

Tip: Access up to 7 years of quarterly data

All positions including Day One Biopharmaceuticals I held by Norges Bank Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Day One Biopharmaceuticals I by Norges Bank Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.5M 169k 14.60
2022-12-31 $2.3M 108k 21.52

More positions owned by Norges Bank Investment Management

Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
UnitedHealth (UNH)
Exxon Mobil Corporation (XOM)
Ubs Group SHS (UBS)
Mastercard Incorporated Cl A (MA)
Home Depot (HD)

View all positions for Norges Bank Investment Management

Top funds holding Day One Biopharmaceuticals I

RA Capital Management
Atlas Venture Life Science Advisors
Vanguard Group
Franklin Resources
Braidwell
Viking Global Investors
T. Rowe Price Associates
Goldman Sachs Group
Deerfield Management Company
First Turn Management
Henderson Group
TimesSquare Capital Management
Partner Fund Management
Boxer Capital
Baker Bros. Advisors

View all funds holding Day One Biopharmaceuticals I